Point72 Hong Kong LTD Eye Point Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $4,308 - $6,883	-619 Reduced 47.11%	695 $5,000
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $8,344 - $14,629	-1,151 Reduced 46.69%	1,314 $10,000
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $4,230 - $6,885	-488 Reduced 16.53%	2,465 $30,000
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $30,061 - $54,335	2,953 New	2,953 $36,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.